DESCRIPTION
The Veterans Health Administration (VHA) Non-Expendable Equipment National Program has identified the Autotransfusion Units product line as a candidate for a VA-wide (otherwise referred to as national ) single Requirements contract award.
The Department of Veterans Affairs (DVA) Office of Procurement, Acquisition and Logistics (OPAL) Enterprise Procurement Office (EPO) on behalf of VHA is issuing this Sources Sought Notice in accordance with the FAR 10.002(b)(2) to determine the availability and technical capabilities of qualified sources.
The EPO in conjunction with VHA is seeking a qualified source to provide Haemonetics Call Saver® Elite® + brand name or equal to Autotransfusion Units on an agency wide basis. VA intends to award a Requirements Contract with Firm-Fixed Price (FFP) orders IAW FAR 16.503, Requirements Contract to a supplier of this equipment. Vendors will be required to deliver the Autotransfusion Units to VA medical centers and facilities throughout the United States and its territories.
The anticipated period of performance is for one 12-month base period with four 12-month option periods from the date of award. However, the Government's decision as to whether to continue with the contract, upon annual review, will be based upon successful performance during each previous year and continued need. The Contractor must demonstrate the ability to meet all requirements for the solicitation.
The associated North American Industrial Classification System (NAICS) code for this procurement is 339112 Surgical and Medical Instrument Manufacturing, Product Service Code: 6515 Medical and Surgical Instruments, Equipment, and Supplies. The FAR Provision found at 52.204-7(b)(1) requires that All interested Offerors must be registered in SAM.gov prior to submitting an offer or quotation. You may access the website at SAM.gov | Home. All offerors must be certified with the appropriate NAICS code on the SAM website. All SDVOSB/VOSB offerors must be verified in the SBA database at: https://veterans.certify.sba.gov/#search at the time of quote submission.
Submissions for this source sought shall be submitted by email no later than September 25, 2026, at 10:00 am EST to all the following:
Sara.Vickroy@va.gov
Jalima.Jones@va.gov
This notice is for planning purposes only and does not constitute a commitment on the part of the Government to award a contract, nor does the Government intend to pay for any information submitted as a result of this notice. This Sources Sought Notice is part of a continuous process for obtaining the latest information on the commercial status of the industry with respect to their current and near-term abilities. The information provided herein is subject to change and in no way binds the Government to solicit for, or award, a competitive contract. It is emphasized that this is a notice solely for planning and informational purposes. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. The Government may or may not issue a solicitation as a result of this notice. There is no solicitation available at this time.
2.0 SCOPE
Autotransfusion Unit, also known as an autologous blood recovery system, is a system that provides hospitals with an easy-to-use, reliable way to recover a patient s own high-quality blood during medium to high blood loss procedures, including cardiac, orthopedic, trauma, transplant, vascular and OBGYN surgeries. Once recovered, the blood is washed and delivered to a product bag. The complete system is designed to be intuitive and flexible for optimal performance, supporting exceptional patient care.
The following Contract Line-Items Number (CLIN) are being considered:
CLIN
Manufacturer
Part Number
Description
0001
Haemonetics
00205-00
RESERVOIR, HARD-SHELL, 150u
0002
Haemonetics
00208-00
BASIC A & A ASSEMBLY, LN 208
0003
Haemonetics
00220-00
RESERVOIR, HARD-SHELL, 20U
0004
Haemonetics
00245-00
RBC BAG W/TWIST-LOCK CONNECTOR
0005
Haemonetics
CSE-B-1000
BAG ASSY, WASTE, 10L
0006
Haemonetics
CSE-FP-125V
CE ELITE FASTPACK,125mL,150u
0007
Haemonetics
CSE-FP-225V
CS ELITE FASTPACK,225ML,150U
0008
Haemonetics
CSE-P-125
CS ELITE PROCESSING KIT, 125ML
0009
Haemonetics
CSE-P-225
CS ELITE PROCESSING KIT, 225ML
0010
Haemonetics
CSE-P-70
CS ELITE PROCESSING KIT, 70ML
0011
Haemonetics
CSE-SQ-1000
SEQUESTRATION KIT, CSE-SQ-1000
0012
Haemonetics
HAR-A-1000
VACUUM LINE, FILTERED
0013
Haemonetics
HAR-A-0013
ASPIRATION & ANTICOAG LINE
0014
Haemonetics
CSE-EX-US
CELL SAVER ELITE PLUS, US
0015
Haemonetics
RECERTIFICATION
ANNUAL ONLINE RECERTIFICATION
0016
Haemonetics
Cellsaver Service
1 Year Platinum Service Agreement
0017
Haemonetics
TRAINING TUITION
Training (Operation of the System)
The Department of Veterans Affairs (VA) is seeking vendors who can provide Haemonetics Call Saver® Elite® + brand name, or equal to Autotransfusion Units as listed above or equal commodities which meet all the following salient characteristics (SCs):
CLIN 0014 applies to the following SCs
SC #
SALIENT CHARACTERISTICS
Applicable CLIN
METHOD OF EVALUATION
SC 1
Collects, separates, washes, and concentrates red blood cells to produce packed RBCs for reinfusion
0014
Literature Review
SC 2
Provides multiple automated processing modes (standard, low volume/pediatric, rapid/emergency) with defined throughput/output rates that support continuous or rapid access to washed RBCs during surgery.
0014
Literature Review
SC 3
Produces high hematocrit washed RBCs with high RBC recovery achieving a strong removal of non RBC components (plasma proteins, free hemoglobin, anticoagulant, potassium, fat).
0014
Literature Review
SC 4
Provides an intuitive touchscreen user interface with guided workflows and clear process / status indicators
0014
Literature Review
SC 5
Compact, mobile system suitable for OR environments, with ergonomic features that support perfusionist / auto transfusionist workflow.
0014
Literature Review
SC 6
Includes alarms and safety interlocks for process parameters, vacuum, fluid levels, and product quality, with reliability appropriate for high use OR settings.
0014
Literature Review
SC 7
Cleared/approved as an autotransfusion device under applicable regulations and standards
0014
Literature Review
CLINs 0001-0013 applies to the following SC
SC #
SALIENT CHARACTERISTICS
Applicable CLIN
METHOD OF EVALUATION
SC 8
Uses single use disposable sets that are quick to install and prime, minimizing setup time and steps.
0001-0013
Literature Review
CLINs 0001-0014 applies to the following SC
SC #
SALIENT CHARACTERISTICS
Applicable CLIN
METHOD OF EVALUATION
SC 9
Supports intraoperative and postoperative autologous blood collection, processing, and reinfusion for medium to high blood loss procedures (cardiac, orthopedic, trauma, vascular, transplant, OBGYN).
0001-0014
Literature Review
For each product (brand name and part number), the response must include descriptive literature demonstrating the product meets or exceeds the salient characteristics specified above.
The Government's intent is to include all ancillary items to ensure the equipment can function as designed by the Original Equipment Manufacturer (OEM) and as clinically required. Vendors are encouraged to provide any product solution or configuration so long as they meet the salient characteristics. Additionally, responses can include any additional product that may be beneficial. These items must be clearly identified by brand name and part number.
Responses to this Sources Sought Notice shall include the following:
Does vendor offer an annual service plan, Yes or No?
If Yes:
What does the plan cover?
Does plan cover software updates only?
Does the plan cover parts repair or replacement only?
Does the plan cover both software and parts?
Vendors are requested to provide documentation that shows information on their service plan.
Is the service provided by the OEM or a subcontractor?
Full name and address of company
CAGE Code/ SAM UIE
Business Size
Manufacturer or Distributor
If the distributor provides full name, business size and address of manufacturer.
Country of Origin designation for all products
Ability to provide uninterrupted supply of products on a national scale.
Technical Literature that clearly shows product(s) meets the identified salient characteristics and page numbers where each salient characteristic is met.
Any additional product solution or configuration that would be beneficial to the clinical functionality of the product line identified.
Authorized Distributor Letter Certified by OEM with a current date.
Although not required, vendors responding to this Sources Sought may also submit a Capabilities Statement.
